PHS
GBT

PFM Health Sciences’s Global Blood Therapeutics, Inc. GBT Stock Holding History

PFM Health Sciences’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-66,967
Closed -$3.23M – 129
2018
Q1 		$3.23M Buy
+66,967
New +$3.74M 0.07% 89
2016
Q3 		– Sell
-1,028,867
Closed -$17.1M – 109
2016
Q2 		$17.1M Buy
1,028,867
+285,881
+38% +$5.77M 0.52% 57
2016
Q1 		$11.8M Buy
742,986
+38,999
+6% +$693K 0.36% 65
2015
Q4 		$22.8M Sell
703,987
-54,829
-7% -$2.37M 0.69% 45
2015
Q3 		$32M Buy
+758,816
New +$35.8M 0.9% 39

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PFM Health Sciences's GBT Position: Q2 2018 in Review

PFM Health Sciences sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2018, closing a stake of 66,967 shares — an estimated $3.23M sold.

PFM Health Sciences first reported a position in GBT in Q3 2015 and held it in 5 quarters. The position peaked at $32M in Q3 2015. 196 funds tracked by Wall St. Rank hold GBT as of Q2 2018.

  • PFM Health Sciences reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • PFM Health Sciences sold 66,967 Global Blood Therapeutics, Inc. shares in Q2 2018, an estimated $3.23M.
  • PFM Health Sciences first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 5 quarters.
  • PFM Health Sciences's Global Blood Therapeutics, Inc. position peaked at $32M in Q3 2015.
  • 196 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2018.

Based on PFM Health Sciences's 13F filing for Q2 2018, filed 14 Aug 2018.